329994615	329994615	CD	B-NP	O
|	|	NN	I-NP	O
SMMC	SMMC	NN	I-NP	O
|	|	NN	I-NP	O
72544371	72544371	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
704390	704390	CD	B-NP	O
|	|	CC	I-NP	O
5/24/1996	5/24/1996	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/20/1996	5/20/1996	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/3/1996	9/3/1996	CD	B-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
4/9/96	4/9/96	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Angioplasty	Angioplasty	JJ	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
RCA	RCA	NN	I-NP	B-protein
and	and	CC	I-NP	O
PDA	PDA	NN	I-NP	O
lesion	lesion	NN	I-NP	O
on	on	IN	B-PP	O
7/24/96	7/24/96	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Carotid	Carotid	NNP	B-NP	O
ultrasound	ultrasound	VBD	B-VP	O
on	on	IN	B-PP	O
7/18/96	7/18/96	CD	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
echo	echo	NN	I-NP	O
on	on	IN	B-PP	O
7/18/96	7/18/96	CD	B-NP	O
.	.	.	O	O

PRIMARY	PRIMARY	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
,	,	,	O	O
STATUS	STATUS	NN	B-NP	O
POST	POST	NN	I-NP	O
ANGIOPLASTY	ANGIOPLASTY	NN	I-NP	O
OF	OF	IN	B-PP	O
A	A	NN	B-NP	B-protein
RCA	RCA	NN	I-NP	I-protein
AND	AND	CC	I-NP	O
PDA	PDA	NN	I-NP	O
LESION	LESION	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
SYNCOPE	SYNCOPE	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
DIABETES	DIABETES	NNP	I-NP	O
MELLITUS	MELLITUS	NNP	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HYPERTENSION	HYPERTENSION	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
HYPERCHOLESTEROLEMIA	HYPERCHOLESTEROLEMIA	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
HYPOTHYROIDISM	HYPOTHYROIDISM	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
GUAIAC	GUAIAC	NN	B-NP	O
POSITIVE	POSITIVE	NN	I-NP	O
STOOL	STOOL	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
VITAMIN	VITAMIN	NN	I-NP	B-protein
B-12	B-12	NN	I-NP	I-protein
DEFICIENCY	DEFICIENCY	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
GALLSTONE	GALLSTONE	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
URINARY	URINARY	NN	I-NP	O
INCONTINENCE	INCONTINENCE	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
A	A	DT	B-NP	O
CYSTOCELE	CYSTOCELE	NN	I-NP	B-DNA
.	.	.	O	O

11	11	CD	B-NP	O
-RRB-	-RRB-	:	O	O
HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
A	A	NN	B-NP	O
FROZEN	FROZEN	NN	I-NP	O
LEFT	LEFT	NN	I-NP	O
SHOULDER	SHOULDER	NN	I-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
63	63	CD	B-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
status	status	NN	I-NP	O
post	post	VBP	B-VP	O
a	a	DT	B-NP	O
syncopal	syncopal	JJ	I-NP	O
episode	episode	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
postmenopausal	postmenopausal	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
denies	deny	VBZ	B-VP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
stable	stable	JJ	I-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
in	in	IN	B-PP	O
January	January	NNP	B-NP	O
of	of	IN	B-PP	O
1992	1992	CD	B-NP	O
notable	notable	JJ	I-NP	O
for	for	IN	B-PP	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
OM2	OM2	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
ostial	ostial	JJ	I-NP	O
right	right	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ETT	ETT	NN	I-NP	O
performed	perform	VBN	B-VP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
1994	1994	CD	B-NP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
exercised	exercise	VBD	B-VP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
minutes	minute	NNS	I-NP	O
42	42	CD	B-NP	O
seconds	second	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
127	127	CD	B-NP	O
,	,	,	O	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
156	156	CD	B-NP	O
,	,	,	O	O
rate	rate	NN	B-NP	O
pressure	pressure	NN	I-NP	O
product	product	NN	I-NP	O
of	of	IN	B-PP	O
20k	20k	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
chest	chest	VB	I-VP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
T	T	NN	I-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inferolateral	inferolateral	NN	I-NP	O
leads	lead	VBZ	B-VP	O
felt	feel	VBD	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
diagnostic	diagnostic	JJ	I-ADJP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
performed	perform	VBN	B-VP	O
in	in	IN	B-PP	O
August	August	NNP	B-NP	O
of	of	IN	B-PP	O
1994	1994	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
60-65	60-65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
followed	follow	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ONNAW	ONNAW	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Stenehjem	Stenehjem	NNP	I-NP	O
,	,	,	O	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Isordil	Isordil	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Captopril	Captopril	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	RB	B-ADVP	O
,	,	,	O	O
enteric	enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Procardia	Procardia	NNP	B-NP	O
XL	XL	NNP	I-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
her	her	PRP$	B-NP	O
angina	angina	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
for	for	IN	B-PP	O
years	year	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
takes	take	VBZ	B-VP	O
1-2	1-2	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
typically	typically	RB	I-VP	O
precipitated	precipitate	VBN	I-VP	O
by	by	IN	B-PP	O
brisk	brisk	JJ	B-NP	O
walking	walking	NN	I-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
exercises	exercise	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
daily	daily	JJ	I-NP	O
workout	workout	NN	I-NP	O
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
situps	situp	NNS	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
usually	usually	RB	B-ADVP	O
a	a	DT	B-NP	O
walk	walk	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
while	while	IN	B-SBAR	O
walking	walk	VBG	B-VP	O
her	her	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
speed	speed	NN	I-NP	O
towards	towards	IN	B-PP	O
the	the	DT	B-NP	O
bus	bus	NN	I-NP	O
station	station	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
some	some	DT	B-NP	O
right	right	JJ	I-NP	O
chest	chest	NN	I-NP	O
wall	wall	NN	I-NP	O
tightness	tightness	NN	I-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
typical	typical	JJ	I-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
middle	middle	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
street	street	NN	I-NP	O
,	,	,	O	O
decided	decide	VBD	B-VP	O
to	to	TO	I-VP	O
walk	walk	VB	I-VP	O
across	across	IN	B-PP	O
the	the	DT	B-NP	O
street	street	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
plan	plan	NN	I-NP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
a	a	DT	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
she	she	PRP	B-NP	O
felt	feel	VBD	B-VP	O
light	light	NN	B-NP	O
headed	head	VBN	B-VP	O
on	on	IN	B-PP	O
continued	continue	VBN	B-NP	O
ambulation	ambulation	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
syncopal	syncopal	JJ	I-NP	O
episode	episode	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
on	on	IN	B-PP	O
awakening	awaken	VBG	B-VP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
confusion	confusion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
report	report	VB	I-VP	O
the	the	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
urine	urine	NN	B-NP	O
incontinence	incontinence	NN	I-NP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
urinary	urinary	JJ	B-NP	O
incontinence	incontinence	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
stool	stool	NN	I-NP	O
incontinence	incontinence	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
seizure	seizure	NN	I-NP	O
activity	activity	NN	I-NP	O
per	per	IN	B-PP	O
observers	observer	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
complications	complication	NNS	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
episode	episode	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
or	or	CC	I-NP	O
PND	PND	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hypercholesterolemia	Hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hypothyroidism	Hypothyroidism	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
guaiac	guaiac	JJ	B-NP	O
positive	positive	JJ	I-NP	O
stools	stool	NNS	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
frozen	frozen	JJ	I-NP	O
shoulder	shoulder	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Vitamin	Vitamin	NN	B-NP	O
B	B	NN	I-NP	O
12	12	CD	I-NP	O
deficiency	deficiency	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Gallstone	Gallstone	NN	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Urinary	Urinary	JJ	B-NP	O
incontinence	incontinence	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
cystocele	cystocele	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Isordil	Isordil	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	O
insulin	insulin	NN	I-NP	O
66	66	CD	B-NP	O
units	unit	NNS	I-NP	O
q.AM	q.AM	NN	B-NP	O
and	and	CC	O	O
15	15	CD	B-NP	O
units	unit	NNS	I-NP	O
q.PM	q.PM	NN	I-NP	O
,	,	,	O	O
Procardia	Procardia	NNP	B-NP	O
XL	XL	NNP	I-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
B	B	NN	I-NP	O
12	12	CD	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
IM	IM	NN	I-NP	O
q.month	q.month	NN	I-NP	O
,	,	,	O	O
Captopril	Captopril	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Synthroid	Synthroid	NNP	B-NP	O
.125	.125	CD	I-NP	O
mg	mg	NN	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
p.r.n.	p.r.n.	FW	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Negative	Negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
mother	mother	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADJP	O
positive	positive	JJ	I-ADJP	O
for	for	IN	B-PP	O
lung	lung	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
in	in	IN	B-PP	O
Ral	Ral	NNP	B-NP	O
,	,	,	O	O
Pennsylvania	Pennsylvania	NNP	B-NP	O
83011	83011	CD	I-NP	O
alone	alone	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
pets	pet	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
ten	ten	CD	B-NP	O
children	child	NNS	I-NP	O
,	,	,	O	O
32	32	CD	B-NP	O
grandchildren	grandchild	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
4	4	CD	B-NP	O
great	great	JJ	I-NP	O
grandchildren	grandchild	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
or	or	CC	O	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
98.9	98.9	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
78	78	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
160/90	160/90	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
room	room	NN	I-NP	O
air	air	NN	I-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
black	black	JJ	I-NP	O
female	female	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
EOMI	EOMI	NN	B-NP	B-protein
,	,	,	O	O
neck	neck	NN	B-NP	O
supple	supple	NN	I-NP	O
,	,	,	O	O
full	full	JJ	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
soft	soft	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
bruit	bruit	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
soft	soft	JJ	I-NP	O
grade	grade	NN	I-NP	O
1/6	1/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
,	,	,	O	O
best	good	JJS	B-NP	O
heard	hear	VBD	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
had	have	VBD	B-VP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
non-tender	non-tender	JJ	B-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
guaiac	guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	O	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
+	+	SYM	I-NP	O
femoral	femoral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
+	+	SYM	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
and	and	CC	O	O
posterior	posterior	JJ	B-NP	O
tibial	tibial	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
grossly	grossly	RB	B-ADJP	O
nonfocal	nonfocal	JJ	I-ADJP	O
.	.	.	O	O

DIAGNOSTIC	DIAGNOSTIC	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
73	73	CD	B-NP	O
,	,	,	O	O
intervals	interval	NNS	B-NP	O
of	of	IN	B-PP	O
.164	.164	CD	B-NP	O
,	,	,	I-NP	O
.076	.076	CD	I-NP	O
,	,	,	I-NP	O
.049	.049	CD	I-NP	O
seconds	second	NNS	I-NP	O
for	for	IN	B-PP	O
PR	PR	NN	B-NP	B-protein
,	,	,	O	O
QRS	QRS	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
QTC	QTC	NNP	B-NP	O
.	.	.	O	O

Axis	Axis	NN	B-NP	O
was	be	VBD	B-VP	O
71	71	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
Q	Q	NN	I-NP	O
waves	wave	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
ST	ST	NN	I-NP	O
or	or	CC	I-NP	O
T	T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
140	140	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.4	4.4	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
103	103	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
25	25	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
16	16	CD	B-NP	O
and	and	CC	I-NP	O
1.3	1.3	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
282	282	CD	B-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	O
of	of	IN	B-PP	O
213	213	CD	B-NP	O
,	,	,	O	O
cholesterol	cholesterol	NN	B-NP	O
179	179	CD	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
labs	lab	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
TSH	TSH	NN	I-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
,	,	,	O	O
ferritin	ferritin	NN	B-NP	B-protein
181	181	CD	I-NP	I-protein
,	,	,	O	O
TIBC	TIBC	NN	B-NP	B-protein
of	of	IN	B-PP	O
226	226	CD	B-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	B-DNA
I	I	PRP	B-NP	I-DNA
was	be	VBD	B-VP	O
0.0	0.0	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
was	be	VBD	B-VP	I-protein
39.4	39.4	CD	B-NP	I-protein
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
7.15	7.15	CD	I-NP	O
,	,	,	O	O
platelet	platelet	NN	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
348	348	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Coagulation	Coagulation	NN	B-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
showed	show	VBD	B-VP	O
2-4	2-4	CD	B-NP	O
WBCs	WBC	NNS	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-cell_line
urine	urine	NN	I-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
revealed	reveal	VBD	B-VP	O
50	50	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
suspected	suspect	VBN	I-NP	O
enteric	enteric	JJ	I-NP	O
gram	gram	NN	I-NP	O
negative	negative	JJ	I-NP	O
rods	rod	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
urine	urine	NN	I-NP	B-cell_line
culture	culture	NN	I-NP	I-cell_line
from	from	IN	B-PP	O
7/24/96	7/24/96	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
infiltrates	infiltrate	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CARDIAC	CARDIAC	NN	B-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
wise	wise	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
by	by	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
and	and	CC	I-NP	O
EKG	EKG	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
standard	standard	JJ	I-NP	O
Bruce	Bruce	NNP	I-NP	O
protocol	protocol	NN	I-NP	O
ETT	ETT	NN	I-NP	O
on	on	IN	B-PP	O
7/10/96	7/10/96	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
exercised	exercise	VBD	B-VP	O
for	for	IN	B-PP	O
8	8	CD	B-NP	O
minutes	minute	NNS	I-NP	O
,	,	,	O	O
stopped	stop	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
fatigue	fatigue	VB	I-VP	O
.	.	.	O	O

Maximum	Maximum	JJ	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
95	95	CD	B-NP	O
,	,	,	O	O
maximum	maximum	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
170/75	170/75	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
developed	develop	VBD	B-VP	O
typical	typical	JJ	B-NP	O
angina	angina	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
recovery	recovery	NN	I-NP	O
which	which	WDT	B-NP	O
spontaneously	spontaneously	RB	B-ADVP	O
resolved	resolve	VBD	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
down	down	IN	B-PP	O
sloping	slop	VBG	B-VP	O
ST	ST	JJ	B-NP	O
segment	segment	NN	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
F	F	NN	B-NP	O
,	,	,	O	O
V4	V4	NN	B-NP	B-protein
through	through	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
into	into	IN	B-PP	O
recovery	recovery	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
less	less	RBR	B-ADJP	O
specific	specific	JJ	I-ADJP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
LVH	LVH	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
7/28/96	7/28/96	CD	B-NP	O
,	,	,	O	O
revealing	reveal	VBG	B-VP	O
a	a	DT	B-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
left	leave	VBD	B-VP	O
main	main	JJ	B-ADJP	O
with	with	IN	B-PP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
origin	origin	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PDA	PDA	NN	I-NP	O
,	,	,	O	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
OM2	OM2	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
angioplasty	angioplasty	JJ	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RCA	RCA	NN	I-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
PDA	PDA	NN	I-NP	O
lesion	lesion	NN	I-NP	O
on	on	IN	B-PP	O
4/1/96	4/1/96	CD	B-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
haze	haze	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
PDA	PDA	NN	I-NP	B-protein
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
recommendations	recommendation	NNS	B-NP	O
were	be	VBD	B-VP	O
for	for	IN	B-PP	O
heparinization	heparinization	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
24	24	CD	I-NP	O
hour	hour	NN	I-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
pain	pain	NN	B-NP	O
free	free	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
EPS	EPS	NNP	I-NP	O
Service	Service	NNP	I-NP	O
saw	see	VBD	B-VP	O
her	her	PRP	B-NP	O
regarding	regard	VBG	B-VP	O
the	the	DT	B-NP	O
issue	issue	NN	I-NP	O
of	of	IN	B-PP	O
syncope	syncope	NN	B-NP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
workup	workup	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
including	include	VBG	B-PP	O
carotid	carotid	NN	B-NP	O
ultrasounds	ultrasound	NNS	I-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
in	in	IN	B-PP	O
either	either	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
carotid	carotid	NN	I-NP	O
arteries	artery	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
on	on	IN	B-PP	O
2/4/96	2/4/96	CD	B-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
regional	regional	JJ	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
that	that	WDT	B-NP	O
might	might	MD	B-VP	O
suggest	suggest	VB	I-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
MI	MI	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
potential	potential	JJ	B-NP	O
ectopy	ectopy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
noted	note	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
74	74	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
reported	report	VBN	I-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
monitors	monitor	NNS	B-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
EPS	EPS	NNP	I-NP	O
Service	Service	NNP	I-NP	O
agreed	agree	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
thought	thought	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
RCA	RCA	NN	I-NP	B-protein
probably	probably	RB	B-ADVP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
likely	likely	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
syncopal	syncopal	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
with	with	IN	B-PP	O
possible	possible	JJ	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
during	during	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
favored	favor	VBD	B-VP	O
holding	hold	VBG	I-VP	O
off	off	RP	B-PRT	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
EPS	EPS	NNP	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
revascularization	revascularization	NN	I-NP	O
and	and	CC	I-NP	O
follow-up	follow-up	JJ	I-NP	O
stress	stress	NN	I-NP	O
testing	testing	NN	I-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
recommended	recommend	VBN	I-NP	O
workup	workup	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	I-NP	O
recommendations	recommendation	NNS	I-NP	O
are	be	VBP	B-VP	O
for	for	IN	B-PP	O
follow-up	follow-up	JJ	B-NP	O
ETT	ETT	NN	I-NP	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
to	to	TO	I-NP	O
six	six	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
adjusted	adjust	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-VP	O
her	her	PRP$	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
from	from	IN	B-PP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
pain	pain	NN	B-NP	O
free	free	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
follow-up	follow-up	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
primary	primary	JJ	I-NP	I-protein
M.D.	M.D.	NNP	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

DIABETES	DIABETES	NNS	B-NP	O
MELLITUS	MELLITUS	NNS	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
glucose	glucose	NN	I-NP	O
remained	remain	VBD	B-VP	O
under	under	IN	B-PP	O
fairly	fairly	RB	B-NP	O
good	good	JJ	I-NP	O
control	control	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
.	.	.	O	O

Hemoglobin	Hemoglobin	NN	B-NP	B-protein
A1C	A1C	NN	I-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
pending	pende	VBG	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

URINARY	URINARY	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
bacteria	bacteria	NNS	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
and	and	CC	I-NP	O
50	50	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
colony	colony	NN	I-NP	O
forming	form	VBG	B-VP	O
units	unit	NNS	B-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
of	of	IN	B-PP	O
7/24/96	7/24/96	CD	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
empirically	empirically	RB	I-VP	O
treat	treat	VB	I-VP	O
her	her	PRP	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
UTI	UTI	NN	I-NP	B-DNA
with	with	IN	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
1	1	CD	I-NP	O
DS	DS	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
times	time	NNS	I-NP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
Follow-up	Follow-up	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Amous	Amous	NNP	I-NP	O
She	She	NNP	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
ETT	ETT	NN	I-NP	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
to	to	TO	I-NP	O
six	six	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
NECTON	NECTON	NNP	I-NP	O
BRYIN	BRYIN	NNP	I-NP	O
HAWEIR	HAWEIR	NNP	I-NP	O
HEALTH	HEALTH	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
follow-up	follow-up	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Enteric	Enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Captopril	Captopril	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Isordil	Isordil	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Synthroid	Synthroid	NNP	B-NP	O
.125	.125	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Procardia	Procardia	NNP	B-NP	O
XL	XL	NNP	I-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
.4	.4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	O
insulin	insulin	NN	I-NP	O
66	66	CD	B-NP	O
units	unit	NNS	I-NP	O
q.AM	q.AM	NN	B-NP	O
and	and	CC	O	O
15	15	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.PM	q.PM	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Bactrim	Bactrim	NN	B-NP	O
1	1	CD	I-NP	O
DS	DS	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
times	time	NNS	I-NP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Discharge	Discharge	NN	B-NP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Good	Good	NNP	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
diet	diet	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
low	low	JJ	B-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
ADA	ADA	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Activity	Activity	NN	B-NP	O
as	as	IN	B-PP	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

COMPLICATIONS	COMPLICATIONS	NNS	B-NP	O
DURING	DURING	VBG	B-VP	O
HOSPITALIZATION	HOSPITALIZATION	NN	B-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
DONALD	DONALD	NNP	B-NP	O
L.	L.	NNP	I-NP	O
MCLAGAN	MCLAGAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
FT15	FT15	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
WESTON	WESTON	NNP	B-NP	O
L.	L.	NNP	I-NP	O
SIKET	SIKET	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
QM24	QM24	NNP	I-NP	O
JC419/8343	JC419/8343	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
73162	73162	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

P6COTZ8ESN	P6COTZ8ESN	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
9/25/96	9/25/96	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/17/96	7/17/96	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

NATHANIAL	NATHANIAL	NNP	B-NP	O
W.	W.	NNP	I-NP	O
NUNN	NUNN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
BZ77	BZ77	NNP	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

JESUS	JESUS	NNP	B-NP	O
R.	R.	NNP	I-NP	O
KRYS	KRYS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
QM24	QM24	NNP	I-NP	O

